1. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells;Amacher,1979
2. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells;Amacher,1980
3. Razoxane (ICRF 159) in the treatment of psoriasis;Atherton;Br. J. Dermatol.,1980
4. A linear relationship between tumorigenic potency in vivo and mutagenic potency at the heterozygous thymidine kinase (TK+/−) locus of L5178Y mouse lymphoma cells coupled with mammalian metabolism;Clive,1977
5. Mutagenicity of hycanthone in mammalian cells;Clive;Mutation Res.,1972